Cite
MLA Citation
David A. Reardon et al.. “Treatment with pembrolizumab in programmed death ligand 1–positive recurrent glioblastoma: Results from the multicohort phase 1 KEYNOTE‐028 trial.” Cancer, vol. 127, no. 10, 2021, pp. 1620–1629. http://access.bl.uk/ark:/81055/vdc_100129522560.0x00005f